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Rare diseases represent an important public-health issue,
affecting 26-30 million persons across Europe, and a
major challenge for research. The fragmentation of
resources and knowledge for the 6000-8000 rare dis-
eases and the lack of efficient treatments for many of
them necessitate a coordinated European approach to
unravel the underlying molecular defects and pathophy-
siological mechanisms. The low number of affected
patients requires transnational collaboration with multi-
disciplinary approaches to map prevalences, build
patient registries, identify biomarkers, develop new diag-
nostics and finally perform clinical studies for the devel-
opment of treatments. To this end, 8 main European
research funding organisations have gathered into the
PF6-funded EC ERA-Net on rare diseases (E-Rare)
(2006-2010) and developed a number of joint activities
regarding systematic exchange of information and best
practises, definition of strategic priorities, and, most
importantly, joint funding activities through the launch
and completion of two fully fledged joint transnational
calls for research projects on rare diseases (2007 and
2009). This exemplary joint funding activity has attested
the need of, and the acknowledgment from, the research
community for transnational funding of collaborative,
multidisciplinary and ambitious projects on rare dis-
eases. It has leveraged funding for rare disease research
in countries that do not have specific programmes for
rare diseases and thus enabled the participation of
researchers in these countries to transnational projects.
A new E-Rare project (E-Rare-2) (2010-2014) aims at
deepening and extending the cooperation among the E-
Rare-1 and four new partner countries by systematic
exchange of information, yearly launched joint calls,
thorough assessment of the funding mechanisms and
results of the funded research projects and, finally, stra-
tegic activities aiming at a sustainable development and
extension of the network. Special attention will be given
to the outreach and knowledge exchange with new
Member States, countries outside of the European
Union and key stakeholders/initiatives important for
rare diseases. E-Rare-2 activities will thus further contri-
bute to reducing fragmentation of research and
resources through the enhanced coordination and trans-
national funding of excellent research on rare diseases,
thereby shaping the European Research Area for rare
diseases.
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